TEACHERS ADVISORS, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$13,527,000
-30.7%
735,161
-1.5%
0.02%
-37.0%
Q4 2018$19,508,000
-41.1%
746,563
-48.2%
0.03%
+35.0%
Q3 2018$33,108,000
+141.3%
1,442,604
+100.3%
0.02%
+17.6%
Q2 2018$13,718,000
+14.5%
720,101
+1.3%
0.02%
+6.2%
Q1 2018$11,979,000
+12.3%
710,928
+1.3%
0.02%
+14.3%
Q4 2017$10,671,000
-14.4%
702,028
+0.8%
0.01%
-17.6%
Q3 2017$12,464,000
+25.3%
696,338
+14.1%
0.02%
+21.4%
Q2 2017$9,949,000
+32.6%
610,338
+13.9%
0.01%
+27.3%
Q1 2017$7,502,000
-11.4%
535,861
+1.0%
0.01%
-15.4%
Q4 2016$8,464,000
+3.5%
530,681
+8.0%
0.01%
-7.1%
Q3 2016$8,176,000
+60.6%
491,341
+8.0%
0.01%
+55.6%
Q2 2016$5,090,000
+920.0%
454,871
+662.6%
0.01%
+800.0%
Q1 2016$499,000
-10.1%
59,6470.0%0.00%0.0%
Q4 2015$555,000
-17.5%
59,6470.0%0.00%0.0%
Q3 2015$673,000
-11.1%
59,6470.0%0.00%0.0%
Q2 2015$757,000
+53.9%
59,647
+12.8%
0.00%0.0%
Q1 2015$492,000
-28.1%
52,893
+10.8%
0.00%0.0%
Q4 2014$684,000
+14.2%
47,754
-17.3%
0.00%0.0%
Q3 2014$599,000
-35.9%
57,7540.0%0.00%
-50.0%
Q2 2014$934,000
+13.8%
57,754
+14.4%
0.00%0.0%
Q1 2014$821,000
+42.5%
50,502
+8.8%
0.00%
+100.0%
Q4 2013$576,000
+22.8%
46,422
+8.7%
0.00%0.0%
Q3 2013$469,000
+64.0%
42,712
+20.7%
0.00%0.0%
Q2 2013$286,00035,3810.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders